| scholarly article | Q13442814 |
| P2093 | author name string | Seema Singh | |
| William E Grizzle | |||
| Bin Wang | |||
| Sumit Arora | |||
| Ajay P Singh | |||
| Arun Bhardwaj | |||
| Sanjeev K Srivastava | |||
| P2860 | cites work | MicroRNA expression profiles in human colorectal cancers with liver metastases | Q95423102 |
| Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
| MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells | Q24630950 | ||
| Structure, evolution, and biology of the MUC4 mucin | Q24630985 | ||
| MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1 | Q24647663 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| Mucins in cancer: protection and control of the cell surface | Q28235006 | ||
| MicroRNAs 103 and 107 regulate insulin sensitivity | Q28240056 | ||
| MicroRNAs in Cancer | Q29615539 | ||
| MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb | Q29619411 | ||
| Pancreatic cancer | Q29622871 | ||
| Muc4/MUC4 functions and regulation in cancer | Q33674729 | ||
| Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive | Q34137381 | ||
| miR 488* inhibits androgen receptor expression in prostate carcinoma cells | Q34196086 | ||
| Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. | Q34292705 | ||
| CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy | Q34363535 | ||
| Expression profiling identifies microRNA signature in pancreatic cancer | Q34588109 | ||
| Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. | Q34603664 | ||
| MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma | Q34604367 | ||
| miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression | Q34762601 | ||
| MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript | Q34804590 | ||
| Pancreatic cancer biology and genetics | Q35013204 | ||
| Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies | Q36300992 | ||
| MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells | Q36858047 | ||
| Pancreatic carcinogenesis | Q37125627 | ||
| MicroRNAs in cancer: small molecules with a huge impact | Q37474280 | ||
| Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways | Q37809242 | ||
| Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals | Q38514376 | ||
| The role of microRNA-150 as a tumor suppressor in malignant lymphoma | Q39556619 | ||
| MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. | Q39753055 | ||
| MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. | Q40150208 | ||
| MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms | Q40262856 | ||
| Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. | Q40671576 | ||
| MicroRNA-based Cancer Therapeutics: Big Hope from Small RNAs | Q41887394 | ||
| MUC4 expression increases progressively in pancreatic intraepithelial neoplasia | Q74385664 | ||
| MicroRNAs as oncogenes and tumor suppressors | Q81406722 | ||
| MUC genes are differently expressed during onset and maintenance of inflammation in dextran sodium sulfate-treated mice | Q82812210 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| microRNA | Q310899 | ||
| P304 | page(s) | 1832-9 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | Carcinogenesis | Q326022 |
| P1476 | title | MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells | |
| P478 | volume | 32 |
| Q35123099 | A microRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapy |
| Q37420793 | Advances in miRNA-Mediated Mucin Regulation. |
| Q34307027 | Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia |
| Q35735278 | Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. |
| Q48239077 | Clinical significance of miRNA-21, -103, -129, -150 in serous ovarian cancer. |
| Q34876404 | Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression |
| Q46314432 | Distinctive microRNA expression signatures in proton-irradiated mice |
| Q33801377 | Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects |
| Q35127888 | Gene expression profiling associated with angiotensin II type 2 receptor-induced apoptosis in human prostate cancer cells |
| Q34657038 | Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine |
| Q36778481 | Genetic risk prediction for normal-karyotype acute myeloid leukemia using whole-exome sequencing |
| Q52584615 | HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development. |
| Q34488314 | High-Throughput miRNA Sequencing Reveals a Field Effect in Gastric Cancer and Suggests an Epigenetic Network Mechanism |
| Q35870123 | Hypoxia promotes C-X-C chemokine receptor type 4 expression through microRNA-150 in pancreatic cancer cells |
| Q41641423 | Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach |
| Q37087374 | Identification of plasma microRNA expression profile in radiographic axial spondyloarthritis-a pilot study. |
| Q26739857 | Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism |
| Q47094133 | Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy |
| Q38688917 | MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma. |
| Q41842858 | MYB is a novel regulator of pancreatic tumour growth and metastasis |
| Q34989346 | MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3 |
| Q38293551 | MiR-150 Regulates Poststroke Cerebral Angiogenesis via Vascular Endothelial Growth Factor in Rats |
| Q30353387 | MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway. |
| Q37504774 | MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4. |
| Q26765233 | MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer |
| Q90312107 | MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential |
| Q38850617 | MicroRNA in pancreatic cancer |
| Q49335684 | MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention. |
| Q28576030 | MicroRNA-150 aggravates H2O2-induced cardiac myocyte injury by down-regulating c-myb gene |
| Q41145017 | MicroRNA-150 functions as an antioncogenic regulator in osteosarcoma |
| Q88639418 | MicroRNA-150 inhibits the proliferation and metastasis potential of colorectal cancer cells by targeting iASPP |
| Q33999853 | MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1 |
| Q36998316 | MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis |
| Q55119430 | MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4. |
| Q35738711 | MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways |
| Q35053672 | MicroRNAs as potential clinical biomarkers: emerging approaches for their detection |
| Q38018097 | MicroRNAs as therapeutic targets and their potential applications in cancer therapy |
| Q38003048 | MicroRNAs in pancreatic cancer metabolism |
| Q37707057 | MicroRNAs in pancreatic malignancy: progress and promises |
| Q36590130 | Modulation of cancer traits by tumor suppressor microRNAs |
| Q42180647 | Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance. |
| Q33624574 | Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward |
| Q26999345 | Molecular mechanism underlying lymphatic metastasis in pancreatic cancer |
| Q37238133 | Mucins and Wnt/β-catenin signaling in gastrointestinal cancers: an unholy nexus |
| Q34260260 | N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis. |
| Q89148846 | Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application |
| Q96609205 | Noncoding RNAs: the shot callers in tumor immune escape |
| Q33881478 | Post-transcriptional processing of genetic information and its relation to cancer |
| Q38442550 | Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma |
| Q26752827 | Prognostic role of microRNA-150 in various carcinomas: a meta-analysis |
| Q38476166 | Receptor for the F4 fimbriae of enterotoxigenic Escherichia coli (ETEC). |
| Q52721823 | Retrospective screening of microarray data to identify candidate IFN-inducible genes in a HTLV-1 transformed model. |
| Q35803040 | Role of microRNA-150 in solid tumors |
| Q64233502 | Role of microRNA-150-5p/SRCIN1 axis in the progression of breast cancer |
| Q47984355 | Role of phytochemicals in the modulation of miRNA expression in cancer |
| Q36341127 | Serum microRNAs as biomarkers for recurrence in melanoma. |
| Q38980514 | Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy |
| Q36540519 | The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma |
| Q34427635 | The expression levels of plasma micoRNAs in atrial fibrillation patients |
| Q34273062 | The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer |
| Q38261312 | The p53/microRNA connection in gastrointestinal cancer |
| Q53071807 | Upregulated miR-106a plays an oncogenic role in pancreatic cancer. |
| Q34722597 | Upregulation of miR-150* and miR-630 induces apoptosis in pancreatic cancer cells by targeting IGF-1R. |
| Q92650173 | lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150 |
| Q35702495 | miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKT |
| Q35061106 | miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor |
| Q28583589 | miR-150 regulates high glucose-induced cardiomyocyte hypertrophy by targeting the transcriptional co-activator p300 |
| Q39017335 | miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer. |
| Q38092617 | miRNA-Based Therapeutic Strategies |
| Q37718685 | miR‑150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma |
| Q36225874 | microRNA signature for human pancreatic cancer invasion and metastasis |
| Q35881270 | microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4. |
Search more.